Literature DB >> 20357094

p62/sequestosome-1 associates with and sustains the expression of retroviral restriction factor TRIM5alpha.

Christopher O'Connor1, Thomas Pertel, Seth Gray, Seth L Robia, Joanna C Bakowska, Jeremy Luban, Edward M Campbell.   

Abstract

TRIM5 proteins mediate a potent block to the cross-species transmission of retroviruses, the most well known being the TRIM5alpha protein from rhesus macaques, which potently inhibits human immunodeficiency virus type 1 (HIV-1) infection. This restriction occurs at an early stage in the replication cycle and is mediated by the binding of TRIM5 proteins to determinants present in the retroviral capsid. TRIM5alpha, as well as other TRIM family proteins, has been shown to be regulated by interferons (IFN). Here we show that TRIM5alpha associates with another IFN-induced gene, sequestosome-1/p62 (p62). p62 plays a role in several signal transduction cascades that are important for maintaining the antiviral state of cells. Here we demonstrate that p62 localizes to both human and rhesus macaque TRIM5alpha cytoplasmic bodies, and fluorescence resonance energy transfer (FRET) analysis demonstrates that these proteins closely associate in these structures. When p62 expression was knocked down via small interfering RNA (siRNA), the number of TRIM5alpha cytoplasmic bodies and the level of TRIM5alpha protein expression were reduced in cell lines stably expressing epitope-tagged versions of TRIM5alpha. In accordance with these data, p62 knockdown resulted in reduced TRIM5alpha-mediated retroviral restriction in cells expressing epitope-tagged TRIM5alpha or expressing endogenously expressed human TRIM5alpha. p62 may therefore operate to enhance TRIM5alpha-mediated retroviral restriction, contributing to the antiviral state of cells following IFN treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20357094      PMCID: PMC2876647          DOI: 10.1128/JVI.02412-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins.

Authors:  Jenny L Anderson; Edward M Campbell; Xiaolu Wu; Nick Vandegraaff; Alan Engelman; Thomas J Hope
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

2.  Alpha interferon enhances TRIM5alpha-mediated antiviral activities in human and rhesus monkey cells.

Authors:  Ryuta Sakuma; Amber A Mael; Yasuhiro Ikeda
Journal:  J Virol       Date:  2007-07-03       Impact factor: 5.103

3.  TRIM22 E3 ubiquitin ligase activity is required to mediate antiviral activity against encephalomyocarditis virus.

Authors:  Patrick Eldin; Laura Papon; Alexandra Oteiza; Emiliana Brocchi; T Glen Lawson; Nadir Mechti
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

Review 4.  Sequestosome 1/p62--more than just a scaffold.

Authors:  M Lamar Seibenhener; Thangiah Geetha; Marie W Wooten
Journal:  FEBS Lett       Date:  2006-12-19       Impact factor: 4.124

5.  p62 serves as a shuttling factor for TrkA interaction with the proteasome.

Authors:  Thangiah Geetha; M Lamar Seibenhener; Li Chen; Kiran Madura; Marie W Wooten
Journal:  Biochem Biophys Res Commun       Date:  2008-07-01       Impact factor: 3.575

6.  The sequestosome 1/p62 attenuates cytokine gene expression in activated macrophages by inhibiting IFN regulatory factor 8 and TNF receptor-associated factor 6/NF-kappaB activity.

Authors:  Ji Young Kim; Keiko Ozato
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

7.  Rapid turnover and polyubiquitylation of the retroviral restriction factor TRIM5.

Authors:  Felipe Diaz-Griffero; Xing Li; Hassan Javanbakht; Byeongwoon Song; Sohanya Welikala; Matthew Stremlau; Joseph Sodroski
Journal:  Virology       Date:  2006-02-10       Impact factor: 3.616

8.  The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.

Authors:  Matthew Stremlau; Christopher M Owens; Michel J Perron; Michael Kiessling; Patrick Autissier; Joseph Sodroski
Journal:  Nature       Date:  2004-02-26       Impact factor: 49.962

9.  Human TRIM gene expression in response to interferons.

Authors:  Laetitia Carthagena; Anna Bergamaschi; Joseph M Luna; Annie David; Pradeep D Uchil; Florence Margottin-Goguet; Walther Mothes; Uriel Hazan; Catherine Transy; Gianfranco Pancino; Sébastien Nisole
Journal:  PLoS One       Date:  2009-03-17       Impact factor: 3.240

10.  TRIM5 alpha cytoplasmic bodies are highly dynamic structures.

Authors:  Edward M Campbell; Mark P Dodding; Melvyn W Yap; Xiaolu Wu; Sarah Gallois-Montbrun; Michael H Malim; Jonathan P Stoye; Thomas J Hope
Journal:  Mol Biol Cell       Date:  2007-03-28       Impact factor: 4.138

View more
  36 in total

1.  Ubiquitin systems mark pathogen-containing vacuoles as targets for host defense by guanylate binding proteins.

Authors:  Arun K Haldar; Clémence Foltz; Ryan Finethy; Anthony S Piro; Eric M Feeley; Danielle M Pilla-Moffett; Masaki Komatsu; Eva-Maria Frickel; Jörn Coers
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-28       Impact factor: 11.205

2.  Hexagonal assembly of a restricting TRIM5alpha protein.

Authors:  Barbie K Ganser-Pornillos; Viswanathan Chandrasekaran; Owen Pornillos; Joseph G Sodroski; Wesley I Sundquist; Mark Yeager
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

3.  Human Trim5α has additional activities that are uncoupled from retroviral capsid recognition.

Authors:  Semih U Tareen; Michael Emerman
Journal:  Virology       Date:  2010-10-28       Impact factor: 3.616

4.  K63-Linked Ubiquitin Is Required for Restriction of HIV-1 Reverse Transcription and Capsid Destabilization by Rhesus TRIM5α.

Authors:  Sabrina Imam; Sevnur Kömürlü; Jessica Mattick; Anastasia Selyutina; Sarah Talley; Amani Eddins; Felipe Diaz-Griffero; Edward M Campbell
Journal:  J Virol       Date:  2019-06-28       Impact factor: 5.103

Review 5.  Precision autophagy directed by receptor regulators - emerging examples within the TRIM family.

Authors:  Tomonori Kimura; Michael Mandell; Vojo Deretic
Journal:  J Cell Sci       Date:  2016-02-15       Impact factor: 5.285

6.  More than one way to TRIM a capsid.

Authors:  Jeremy Luban
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-13       Impact factor: 11.205

7.  TRIM proteins regulate autophagy and can target autophagic substrates by direct recognition.

Authors:  Michael A Mandell; Ashish Jain; John Arko-Mensah; Santosh Chauhan; Tomonori Kimura; Christina Dinkins; Guido Silvestri; Jan Münch; Frank Kirchhoff; Anne Simonsen; Yongjie Wei; Beth Levine; Terje Johansen; Vojo Deretic
Journal:  Dev Cell       Date:  2014-08-07       Impact factor: 12.270

8.  Role of p62/SQSTM1 beyond autophagy: a lesson learned from drug-induced toxicity in vitro.

Authors:  Fernando Alegre; Ángela B Moragrega; Miriam Polo; Alberto Marti-Rodrigo; Juan V Esplugues; Ana Blas-Garcia; Nadezda Apostolova
Journal:  Br J Pharmacol       Date:  2018-01-06       Impact factor: 8.739

9.  Functional evidence for the involvement of microtubules and dynein motor complexes in TRIM5α-mediated restriction of retroviruses.

Authors:  Paulina Pawlica; Valerie Le Sage; Nolwenn Poccardi; Michel J Tremblay; Andrew J Mouland; Lionel Berthoux
Journal:  J Virol       Date:  2014-03-05       Impact factor: 5.103

Review 10.  Autophagy as an innate immunity paradigm: expanding the scope and repertoire of pattern recognition receptors.

Authors:  Vojo Deretic
Journal:  Curr Opin Immunol       Date:  2011-11-24       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.